DC Chemicals

All products / DC66534

VK-2019
CAT. NO. DC66534

VK-2019

Pack sizes and prices

Pack sizePrice
100mg$750 USDRequest a quote / confirm availability →
250mg$1,200 USDRequest a quote / confirm availability →
1g$2,500 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

VK-2019 is a selective EBNA1 inhibitor. VK-2019 was developed as a highly specific inhibitor of EBNA1 DNA binding activity and is currently in phase 1 development as a treatment for EBV-associated carcinomas. EBNA1 is an Epstein Barr virus (EBV) protein expressed in all EBV-associated cancers. EBNA1 plays a critical role in the replication and maintenance of EBV episomes in latently infected cells.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC66534
Product nameVK-2019
CAS2044520-06-9
Molecular formulaC29H25NO4
Molecular weight451.51310801506
Purity>98%
SMILESO=C(O)c1cccc(C#Cc2ccc(COC3CCOCC3)cc2)c1-c1ccc2cc[nH]c2c1

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — VK-2019 (DC66534)

Related research products

Browse newly added products